l 012 has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aramaki, Y; Hada, T; Hatanaka, M; Ichimori, Y; Ii, M; Masuya, H; Terada, M; Yoshida, H | 1 |
1 other study(ies) available for l 012 and Bladder Cancer
| Article | Year |
|---|---|
Improved enzyme immunoassay for human basic fibroblast growth factor using a new enhanced chemiluminescence system.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Brain Neoplasms; Fibroblast Growth Factor 2; Humans; Immunoenzyme Techniques; Indicators and Reagents; Kidney Neoplasms; Liver Neoplasms; Luminescent Measurements; Luminol; Lung Neoplasms; Neoplasms; Reference Values; Stomach Neoplasms; Urinary Bladder Neoplasms | 1993 |